Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

珍宝岛 - NMPA Drug Approval Details

Approvals/NMPA/珍宝岛

Approved

中药

珍宝岛

黑龙江珍宝岛药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Jun 22, 2020
Approval ID: 7Leaf0XIDEp
Company: 黑龙江珍宝岛药业股份有限公司
Type: 中药

Approval Details

Approval Id: 7Leaf0XIDEp
Approval Number: 国药准字Z20026049
Generic Name: 复方芩兰口服液
Brand Name: 珍宝岛
Drug Type: 中药
Dosage Form: 合剂
Strength: 每支装10毫升
Reg Date: 2020-06-22
Company Name: 黑龙江珍宝岛药业股份有限公司
Company Address: 黑龙江省鸡西市虎林市虎林镇红星街72号
Production Company Name: 黑龙江珍宝岛药业股份有限公司;黑龙江羽迪药业有限责任公司
Production Company Address: 黑龙江省虎林市红星街72号；黑龙江省鸡西市密山市裴德镇013幢
Company Detail Path: /organization/heilongjiang-zbd-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 22, 2020

Approval ID

7Leaf0XIDEp

Type

中药

Back to NMPA Approvals